Weight-Based Dosing in Pediatric Patients
For most pediatric patients, you should use actual body weight for medication dosing, not ideal body weight (IBW), as actual body weight closely approximates IBW in non-obese children and provides the most accurate dosing for resuscitation and most medications. 1
General Dosing Principles
Non-Obese Pediatric Patients
- Use actual body weight for all medication calculations in children who are not obese, as this closely approximates their ideal body weight and provides appropriate dosing 1
- If the child's weight is unknown, length-based estimation tapes (such as Broselow tapes) are more accurate than age-based estimates and should be used 1, 2
- Length-based tapes estimate the 50th percentile weight for length, which effectively represents ideal body weight 1
Obese Pediatric Patients
For obese children, use ideal body weight (estimated from length) for initial resuscitation drug doses to avoid potential toxicity from overdosing. 1
- Using actual body weight in obese patients may result in potentially toxic doses of resuscitation medications 1
- However, there is no strong evidence about safety and efficacy of dose adjustments in obese children, making this a theoretical concern rather than evidence-based 1
- For subsequent doses in obese patients, titrate to clinical effect and observed toxicities, not exceeding adult maximum doses 1
Context-Specific Exceptions
Tuberculosis Treatment
For tuberculosis medications specifically, dose calculations are based on ideal body weight, with children weighing more than 40 kg dosed as adults. 1
- This represents a specific exception where IBW is explicitly recommended by the ATS, CDC, and IDSA guidelines 1
Resuscitation Medications
- The 2020 American Heart Association guidelines provide a Class 1 recommendation (strongest level) to use the child's body weight for calculating resuscitation drug doses 1
- This applies regardless of body habitus for initial dosing 1
- Never exceed the recommended adult dose regardless of the child's weight 1
Important Caveats and Pitfalls
Weight Estimation Challenges
- Length-based tapes with precalculated doses are validated and more accurate than provider estimates 1, 2
- The Broselow tape shows 79% accuracy within 15% error for children, with highest accuracy between 3.5-25 kg 2
- Including body habitus measurements may improve accuracy of length-based weight estimates 1
Documentation Requirements
- Patient weight in kilograms should be documented on all medication prescriptions to enable proper pharmacist verification 3
- Without documented weight, community pharmacists cannot verify appropriate weight-based dosing 3
Obesity Considerations
- There is no consensus on the best method to calculate IBW in pediatric patients, with multiple methods yielding statistically different results 4
- Implementation of IBW and adjusted body weight calculators in electronic health records improved appropriate dosing adherence from 1.2% to 24.2% in obese pediatric patients 5
- For immune globulin specifically in obese children, using appropriate weight-based dosing (rather than total body weight) resulted in significant cost savings without compromising efficacy 5
Medication-Specific Guidance
- Some medications have narrow therapeutic indices and require more careful weight-based calculations 5
- For medications with significant toxicity risks (such as chemotherapy or certain antibiotics), ideal body weight may be more appropriate in obese patients 5
- Always verify drug-specific dosing recommendations, as some medications explicitly require IBW while others require actual body weight 1